Gene · 4299
Papers2,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neuroinflammation and Parkinson's Disease-From Neurodegeneration to Therapeutic Opportunities. | Cells | 2022 | 36139483 | PubTator, text mining | PubMed |
| Bioinformatic Analyses of Broad H3K79me2 Domains in Different Leukemia Cell Line Data Sets. | Cells | 2022 | 36139405 | PubTator, text mining | PubMed |
| Genomics and epigenetics guided identification of tissue-specific genomic safe harbors. | Genome Biol | 2022 | 36131352 | PubTator, text mining | PubMed |
| Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia. | FASEB J | 2022 | 36106439 | PubTator, text mining | PubMed |
| Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia. | Front Oncol | 2022 | 36106118 | PubTator, text mining | PubMed |
| Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia. | Nat Commun | 2022 | 36104354 | PubTator, text mining | PubMed |
| Multistate structures of the MLL1-WRAD complex bound to H2B-ubiquitinated nucleosome. | Proc Natl Acad Sci U S A | 2022 | 36095189 | PubTator, text mining | PubMed |
| CRISPR-Cas9-directed gene tagging using a single integrase-defective lentiviral vector carrying a transposase-based Cas9 off switch. | Mol Ther Nucleic Acids | 2022 | 36090759 | PubTator, text mining | PubMed |
| Changing Landscape in the Treatment of Adult Acute Lymphoblastic Leukemia (ALL). | Cancers (Basel) | 2022 | 36077822 | PubTator, text mining | PubMed |
| Recurrent Translocations in Topoisomerase Inhibitor-Related Leukemia Are Determined by the Features of DNA Breaks Rather Than by the Proximity of the Translocating Genes. | Int J Mol Sci | 2022 | 36077220 | PubTator, text mining | PubMed |
| Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia. | Cancer Discov | 2022 | 36053276 | PubTator, text mining | PubMed |
| Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy. | Explor Target Antitumor Ther | 2022 | 36046845 | PubTator, text mining | PubMed |
| Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia. | Nat Commun | 2022 | 36042201 | PubTator, text mining | PubMed |
| Negative Feedback Loop Mechanism between EAF1/2 and DBC1 in Regulating ELL Stability and Functions. | Mol Cell Biol | 2022 | 36036574 | PubTator, text mining | PubMed |
| Application of CRISPR-Cas9 Gene Editing for HIV Host Factor Discovery and Validation. | Pathogens | 2022 | 36015010 | PubTator, text mining | PubMed |
| MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools. | Cancers (Basel) | 2022 | 36010971 | PubTator, text mining | PubMed |
| Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation. | Front Endocrinol (Lausanne) | 2022 | 36004349 | PubTator, text mining | PubMed |
| AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination. | Sci Adv | 2022 | 36001653 | PubTator, text mining | PubMed |
| MiR-27a downregulates 14-3-3θ, RUNX1, AF4, and MLL-AF4, crucial drivers of blast transformation in t(4;11) leukemia cells. | Cell Biochem Funct | 2022 | 35981137 | PubTator, text mining | PubMed |
| Pharmacogenomic Profiling of Pediatric Acute Myeloid Leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision Medicine. | Blood Cancer Discov | 2022 | 35960210 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4299/papers?page=17